297 related articles for article (PubMed ID: 27862966)
1. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.
Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y
J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966
[TBL] [Abstract][Full Text] [Related]
2. The condensin component NCAPG2 regulates microtubule-kinetochore attachment through recruitment of Polo-like kinase 1 to kinetochores.
Kim JH; Shim J; Ji MJ; Jung Y; Bong SM; Jang YJ; Yoon EK; Lee SJ; Kim KG; Kim YH; Lee C; Lee BI; Kim KT
Nat Commun; 2014 Aug; 5():4588. PubMed ID: 25109385
[TBL] [Abstract][Full Text] [Related]
3. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.
Zhan P; Zhang B; Xi GM; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu QQ; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Qian LP; Lv TF; Song Y
Mol Cancer; 2017 Jun; 16(1):108. PubMed ID: 28646916
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone receptor interactor 13 (TRIP13) overexpression associated with tumor progression and poor prognosis in lung adenocarcinoma.
Li W; Zhang G; Li X; Wang X; Li Q; Hong L; Shen Y; Zhao C; Gong X; Chen Y; Zhou J
Biochem Biophys Res Commun; 2018 May; 499(3):416-424. PubMed ID: 29567476
[TBL] [Abstract][Full Text] [Related]
5. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway.
Yang ZT; Li Z; Wang XG; Tan T; Yi F; Zhu H; Zhao JP; Zhou XF
Cell Physiol Biochem; 2015; 35(6):2360-70. PubMed ID: 25896422
[TBL] [Abstract][Full Text] [Related]
7. LSD1 Inhibition Attenuates Tumor Growth by Disrupting PLK1 Mitotic Pathway.
Dalvi PS; Macheleidt IF; Lim SY; Meemboor S; Müller M; Eischeid-Scholz H; Schaefer SC; Buettner R; Klein S; Odenthal M
Mol Cancer Res; 2019 Jun; 17(6):1326-1337. PubMed ID: 30760542
[TBL] [Abstract][Full Text] [Related]
8. NCAPG2 facilitates glioblastoma cells' malignancy and xenograft tumor growth via HBO1 activation by phosphorylation.
Wu J; Li L; Jiang G; Zhan H; Zhu X; Yang W
Cell Tissue Res; 2021 Feb; 383(2):693-706. PubMed ID: 32897418
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer.
Chi F; Wang Z; Li Y; Chang N
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181475
[TBL] [Abstract][Full Text] [Related]
10. Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells.
Zhong N; Shi S; Wang H; Wu G; Wang Y; Ma Q; Wang H; Liu Y; Wang J
Int J Oncol; 2016 Sep; 49(3):1028-38. PubMed ID: 27571708
[TBL] [Abstract][Full Text] [Related]
11. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
[TBL] [Abstract][Full Text] [Related]
12. Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.
Qiao Y; Chen J; Ma C; Liu Y; Li P; Wang Y; Hou L; Liu Z
Cell Physiol Biochem; 2018; 51(1):1-10. PubMed ID: 30439711
[TBL] [Abstract][Full Text] [Related]
13. Short hairpin RNA-mediated down-regulation of CENP-A attenuates the aggressive phenotype of lung adenocarcinoma cells.
Wu Q; Chen YF; Fu J; You QH; Wang SM; Huang X; Feng XJ; Zhang SH
Cell Oncol (Dordr); 2014 Dec; 37(6):399-407. PubMed ID: 25228009
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
[No Abstract] [Full Text] [Related]
15. Bmi-1-shRNA inhibits the proliferation of lung adenocarcinoma cells by blocking the G1/S phase through decreasing cyclin D1 and increasing p21/p27 levels.
Zheng X; Wang Y; Liu B; Liu C; Liu D; Zhu J; Yang C; Yan J; Liao X; Meng X; Yang H
Nucleic Acid Ther; 2014 Jun; 24(3):210-6. PubMed ID: 24552182
[TBL] [Abstract][Full Text] [Related]
16. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
17. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
Zhang L; Zhou XF; Pan GF; Zhao JP
Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
[TBL] [Abstract][Full Text] [Related]
19. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B; Wang R; Chen LB
Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression.
Shi Y; Mao Z; Huang Y; Sun Y; Cao Q; Yin X; Huang J; Zhang Q
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32211805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
